Different missense mutations in histidine-108 of lysosomal acid lipase cause cholesteryl ester storage disease in unrelated compound heterozygous and hemizygous individuals
- 1 January 1998
- journal article
- research article
- Published by Hindawi Limited in Human Mutation
- Vol. 12 (1) , 44-51
- https://doi.org/10.1002/(sici)1098-1004(1998)12:1<44::aid-humu7>3.0.co;2-o
Abstract
Cholesteryl ester storage disease (CESD) and Wolman disease (WD) are both autosomal recessive disorders associated with reduced activity of lysosomal acid lipase (LAL), that leads to the tissue accumulation of cholesteryl esters in endosomes and lysosomes. WD is caused by genetic defects of LAL that leave no residual enzymatic activity, while in CESD patients a residual LAL activity can be identified. We have analyzed the LAL cDNA in three CESD patients from two nonrelated families and identified the mutations responsible for the disease. The associated genetic defects characterized revealed compound heterozygosity for a splice defect leading to skipping of exon 8, due to a G→A transition at position –1 of the exon 8 splice donor site, and a point mutation leading to a His108Pro change (CAT→CCT) in two patients (siblings) with mild CESD phenotype. A further CESD patient was hemizygous for a His108→Arg missense mutation (CAT→CGT) in combination with a partial deletion of the LAL gene and was affected more severely. Expression of the LAL enzymes with the His108→Pro and His108→Arg mutation in insect cells revealed residual enzymatic activities of 4.6% versus 2.7%, respectively, compared with controls. Therefore, His108 seems to play a crucial role in folding or catalytic activity of the lysosomal acid lipase. This is the first description of two different, naturally occurring mutations involving the same amino acid residue in the lysosomal acid lipase in unrelated CESD patients. Moreover, our results demonstrate that the variable manifestation of CESD can be explained by mutation‐dependent, variable inactivation of the LAL enzyme. Hum Mutat 12:44–51, 1998.Keywords
This publication has 16 references indexed in Scilit:
- Genetic and Biochemical Evidence That CESD and Wolman Disease Are Distinguished by Residual Lysosomal Acid Lipase ActivityGenomics, 1996
- A Novel Variant of Lysosomal Acid Lipase (Leu 336 →Pro) Associated With Acid Lipase Deficiency and Cholesterol Ester Storage DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Tri- and tetranucleotide repeat polymorphism in the LIPA geneHuman Molecular Genetics, 1994
- Mutations at the lysosomal acid cholesteryl ester hydrolase gene locus in Wolman disease.Proceedings of the National Academy of Sciences, 1994
- Genomic Organization of the Human Lysosomal Acid Lipase Gene (LIPA)Genomics, 1994
- A splice junction mutation causes deletion of a 72-base exon from the mRNA for lysosomal acid lipase in a patient with cholesteryl ester storage disease.Journal of Clinical Investigation, 1993
- Cholesterol homeostasis in mononuclear leukocytes from patients with familial hypercholesterolemia treated with lovastatin.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1989
- A simple salting out procedure for extracting DNA from human nucleated cellsNucleic Acids Research, 1988
- Genetic variation of human mononuclear leukocyte lysosomal acid lipase activityAtherosclerosis, 1986
- The Low-Density Lipoprotein Pathway and its Relation to AtherosclerosisAnnual Review of Biochemistry, 1977